Member since 22 December 201701 February 2018 at 14:29
The so-called racial gap in breast cancer care has long been suggested by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. Researchers claim financial factors such as economic and social class or access to insurance alone can't explain this "gap”. Even after accounting for those differences, racial disparities in breast cancer care can still be found. For hormone receptor testing there may not be such differences but the gap persists in other interventions. For instance, black women have lower odds of receiving recommended treatments: interventions like mastectomy or breast-conserving therapy or even chemotherapy. The sad part is, these disparities persist even after many studies accounted for insurance coverage and socioeconomic status. People often are quick to blame the so-called "racial gap" on income or insurance, but the fact that the gap exists independently of these factors clearly hints there are more "hidden" racial biases in our healthcare system.
This is one of those 'beliefs' that pop up from time to time. There is no proven link between deodorant use and breast cancer. Any studies completed to date have not been adequate to show proof. There are lots of things that are believed to cause cancer and very few of them have been proven because ....
Imagine going in for a cancer screening, and the technician turns to you and says, "We're finished, but if I push this button over here, the machine can detect even smaller cancers. But here's the hitch: You have to pay $700 if you want me to push this button." Myriad Genetics is doing something ve....
Nidii Berwal
The so-called racial gap in breast cancer care has long been suggested by researchers, with black and Hispanic women less likely to get recommended breast cancer treatments than white patients. Researchers claim financial factors such as economic and social class or access to insurance alone can't explain this "gap”. Even after accounting for those differences, racial disparities in breast cancer care can still be found. For hormone receptor testing there may not be such differences but the gap persists in other interventions. For instance, black women have lower odds of receiving recommended treatments: interventions like mastectomy or breast-conserving therapy or even chemotherapy. The sad part is, these disparities persist even after many studies accounted for insurance coverage and socioeconomic status. People often are quick to blame the so-called "racial gap" on income or insurance, but the fact that the gap exists independently of these factors clearly hints there are more "hidden" racial biases in our healthcare system.